Europe Upstream Bioprocessing Market Forecast to 2030 - Regional analysis - by Product Type, Workflow, Usage Type, and Mode

Description

List of Tables

The Europe upstream bioprocessing market was valued at US$ 2,581.59 million in 2022 and is expected to reach US$ 7,069.78 million by 2030; it is estimated to grow at a CAGR of 13.4% from 2022 to 2030.

Outsourcing of Biopharmaceutical Manufacturing Drives Europe Upstream Bioprocessing Market

A large number of contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs) are engaging in bioprocessing activities, which triggers the demand for bioreactors in these facilities. The strategic outsourcing of pharmaceutical manufacturing through bioprocessing allows biopharmaceutical companies to leverage external partners' expertise and advanced capabilities in upstream processes, facilitating access to specialized technologies, process optimization expertise, and scalable manufacturing capacity. By partnering with CDMOs and CMOs, biopharmaceutical firms can efficiently manage manufacturing needs, accommodate fluctuations in production demands, and focus on core research and development activities. Additionally, outsourcing offers cost efficiencies and risk mitigation by leveraging external partners' established infrastructure and regulatory-compliant facilities. Outsourcing the bioprocessing functions allows biopharmaceutical companies to focus on fostering innovation, technological advancements, and overall upstream process expansion. Thus, the outsourcing of biopharmaceutical manufacturing significantly drives the growth of the upstream bioprocessing market.

Europe Upstream Bioprocessing Market Overview

The Europe upstream bioprocessing market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. It is expected to register a robust growth rate owing to the availability of government and private funding for research in biologics and pharmaceuticals, leading to the launch of innovative technologies. The region has various organizations and bodies that monitor the practices being carried out in the pharmaceutical industry through conferences and other events. Companies in Europe have been focusing on showcasing their products at various events to be able to strengthen their customer base and collect information regarding developments made by any other players in the region. Thus, research initiatives, innovative products, and events such as conferences benefit the upstream bioprocessing market in Europe.

Europe Upstream Bioprocessing Market Revenue and Forecast to 2030 (US$ Million)

Europe Upstream Bioprocessing Market Segmentation

The Europe upstream bioprocessing market is segmented based on product type, workflow, usage type, mode, and country. Based on product type, the Europe upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The bioreactors/fermenters services held the largest market share in 2022.

Based on workflow, the Europe upstream bioprocessing market is categorized into media preparation, cell culture, and cell separation. The cell separation held the largest market share in 2022.

Based on usage type, the Europe upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use held a larger market share in 2022

Based on mode, the Europe upstream bioprocessing market is bifurcated into In-house and outsourced. The In-house held a larger market share in 2022.

Based on country, the Europe upstream bioprocessing market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe upstream bioprocessing market share in 2022.

Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Cellexus International Ltd, Sartorius AG, Getinge AB, Merck KGaA, Corning Inc, and Entegris Inc are some of the leading companies operating in the Europe upstream bioprocessing market.

Product Code: BMIRE00030684

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Upstream Bioprocessing Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Europe Upstream Bioprocessing Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Commercial Use of Single-Use Bioreactors
- 5.1.2 Outsourcing of Biopharmaceutical Manufacturing
- 5.1.3 Rapid Growth of Pharmaceutical and Biotechnology Industries
5.2 Market Restraints
- 5.2.1 Stringent Regulatory Framework
5.3 Market Opportunities
- 5.3.1 Technological Advancements
5.4 Future Trends
- 5.4.1 Increasing Investments in R&D in Biopharmaceutical Industry
5.5 Impact of Drivers and Restraints:

6. Upstream Bioprocessing Market - Europe Analysis

7. Europe Upstream Bioprocessing Market Analysis - by Product Type

7.1 Bioreactors/Fermenters
- 7.1.1 Overview
- 7.1.2 Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Cell Culture
- 7.2.1 Overview
- 7.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Filters
- 7.3.1 Overview
- 7.3.2 Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Bags and Containers
- 7.4.1 Overview
- 7.4.2 Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Upstream Bioprocessing Market Analysis - by Workflow

8.1 Media Preparation
- 8.1.1 Overview
- 8.1.2 Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Cell Culture
- 8.2.1 Overview
- 8.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Cell Separation
- 8.3.1 Overview
- 8.3.2 Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Upstream Bioprocessing Market Analysis - by Usage Type

9.1 Single-use
- 9.1.1 Overview
- 9.1.2 Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Multi-use
- 9.2.1 Overview
- 9.2.2 Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Upstream Bioprocessing Market Analysis - by Mode

10.1 In-house
- 10.1.1 Overview
- 10.1.2 In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
10.2 Outsourced
- 10.2.1 Overview
- 10.2.2 Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Upstream Bioprocessing Market - Country Analysis

11.1 Europe Market Overview
- 11.1.1 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
  - 11.1.1.1 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
  - 11.1.1.2 UK
  - 11.1.1.3 UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.1.3.1 UK: Upstream Bioprocessing Market Breakdown, by Product Type
    - 11.1.1.3.2 UK: Upstream Bioprocessing Market Breakdown, by Workflow
    - 11.1.1.3.3 UK: Upstream Bioprocessing Market Breakdown, by Usage Type
    - 11.1.1.3.4 UK: Upstream Bioprocessing Market Breakdown, by Mode
  - 11.1.1.4 Germany
  - 11.1.1.5 Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.1.5.1 Germany: Upstream Bioprocessing Market Breakdown, by Product Type
    - 11.1.1.5.2 Germany: Upstream Bioprocessing Market Breakdown, by Workflow
    - 11.1.1.5.3 Germany: Upstream Bioprocessing Market Breakdown, by Usage Type
    - 11.1.1.5.4 Germany: Upstream Bioprocessing Market Breakdown, by Mode
  - 11.1.1.6 France
  - 11.1.1.7 France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.1.7.1 France: Upstream Bioprocessing Market Breakdown, by Product Type
    - 11.1.1.7.2 France: Upstream Bioprocessing Market Breakdown, by Workflow
    - 11.1.1.7.3 France: Upstream Bioprocessing Market Breakdown, by Usage Type
    - 11.1.1.7.4 France: Upstream Bioprocessing Market Breakdown, by Mode
  - 11.1.1.8 Italy
  - 11.1.1.9 Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.1.9.1 Italy: Upstream Bioprocessing Market Breakdown, by Product Type
    - 11.1.1.9.2 Italy: Upstream Bioprocessing Market Breakdown, by Workflow
    - 11.1.1.9.3 Italy: Upstream Bioprocessing Market Breakdown, by Usage Type
    - 11.1.1.9.4 Italy: Upstream Bioprocessing Market Breakdown, by Mode
  - 11.1.1.10 Spain
  - 11.1.1.11 Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.1.11.1 Spain: Upstream Bioprocessing Market Breakdown, by Product Type
    - 11.1.1.11.2 Spain: Upstream Bioprocessing Market Breakdown, by Workflow
    - 11.1.1.11.3 Spain: Upstream Bioprocessing Market Breakdown, by Usage Type
    - 11.1.1.11.4 Spain: Upstream Bioprocessing Market Breakdown, by Mode
  - 11.1.1.12 Rest of Europe
  - 11.1.1.13 Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.1.13.1 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Product Type
    - 11.1.1.13.2 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Workflow
    - 11.1.1.13.3 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Usage Type
    - 11.1.1.13.4 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Mode

12. Industry Landscape

12.1 Overview
12.2 Growth Strategies in Upstream Bioprocessing Market
12.3 Organic Growth Strategies
- 12.3.1 Overview
12.4 Inorganic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 Thermo Fisher Scientific Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Esco Micro Pte Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Cellexus International Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Sartorius AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Getinge AB
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Merck KGaA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Corning Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Entegris Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms